Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy

Nature Communications

Volumn 5, Issue , 2014, Pages

  Valdés Mas, Rafael ^a   Gutiérrez Fernández, Ana ^a   Gómez, Juan ^b   Coto, Eliecer ^b,c   Astudillo, Aurora ^d   Puente, Diana A ^a   Reguero, Julián R ^d   Álvarez, Victoria ^b   Morís, César ^c,d   León, Diego ^d   Martín, María ^d   Puente, Xose S ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Geendiab Grupo Espanol de Estud de la Nefropatia Diabetica Working Grp from the Span Soc of Nephrology   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARRIER PROTEINS AND BINDING PROTEINS; CREATINE KINASE; FILAMIN C; UNCLASSIFIED DRUG; FILAMIN;

HYPERTROPHIC ENVIRONMENT; MUSCLE; MUTATION; PROTEIN;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FAMILY HISTORY; FEMALE; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART OUTFLOW TRACT OBSTRUCTION; HUMAN; HUMAN TISSUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; MYOBLAST; ONSET AGE; STOP CODON; SUDDEN CARDIAC DEATH; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DNA SEQUENCE; EXOME; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE; RAT; ULTRASTRUCTURE; YOUNG ADULT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; EXOME; FEMALE; FILAMINS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYOCARDIUM; MYOCYTES, CARDIAC; PEDIGREE; RATS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84923331970     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6326     Document Type: Article

References (33)

1. Maron, B. J. et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 92, 785-789 (1995).
2. Gersh, B. J. et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Circulation 124, 2761-2796 (2011).
3. Seidman, C. E. & Seidman, J. G. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ. Res. 108, 743-750 (2011).
4. Maron, M. S. A paradigm shift in our understanding of the development of the hypertrophic cardiomyopathy phenotype?: not so fast! Circulation 127, 10-12 (2013).
5. Puente, X. S. et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 88, 650-656 (2011).
6. Bochukova, E. et al. A mutation in the thyroid hormone receptor alpha gene. New Engl. J. Med. 366, 243-249 (2012).
7. Crotti, L. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 127, 1009-1017 (2013).
8. Mestroni, L. et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the european human and capital mobility project on familial dilated cardiomyopathy. Eur. Heart. J. 20, 93-102 (1999).
9. Maron, B. J. et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll. Cardiol. 42, 1687-1713 (2003).
10. Osio, A. et al. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ. Res. 100, 766-768 (2007).
11. Ruggiero, A., Chen, S. N., Lombardi, R., Rodriguez, G. & Marian, A. J. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity. Cardiovasc. Res. 97, 44-54 (2012).
12. Vorgerd, M. et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am. J. Hum. Genet. 77, 297-304 (2005).
13. Kley, R. A. et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 130, 3250-3264 (2007).
14. Luan, X., Hong, D., Zhang, W., Wang, Z. & Yuan, Y. A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul. Disord. 20, 390-396 (2010).
15. Shatunov, A. et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur. J. Hum. Genet. 17, 656-663 (2009).
16. Fürst, D. O. et al. Filamin C-related myopathies: pathology and mechanisms. Acta Neuropathol. 125, 33-46 (2013).
17. Meredith, C. et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am. J. Hum. Genet. 75, 703-708 (2004).
18. Frey, N., Luedde, M. & Katus, H. A. Mechanisms of disease: hypertrophic cardiomyopathy. Nat. Rev. Cardiol. 9, 91-100 (2012).
19. Schreiber, K. H. & Kennedy, B. K. When lamins go bad: nuclear structure and disease. Cell 152, 1365-1375 (2013).
20. Cattin, M. E., Muchir, A. & Bonne, G. 'State-of-the-heart' of cardiac laminopathies. Curr. Opin. Cardiol. 28, 297-304 (2013).
21. Worman, H. J. Nuclear lamins and laminopathies. J. Pathol. 226, 316-325 (2012).
22. Friedrich, F. W. et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum. Mol. Genet. 21, 3237-3254 (2012).
23. Hartmannova, H. et al. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene. Circ. Cardiovasc. Genet. 6, 543-551 (2013).
24. Dalkilic, I., Schienda, J., Thompson, T. G. & Kunkel, L. M. Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure. Mol. Cell Biol. 26, 6522-6534 (2006).
25. Fujita, M. et al. Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro. Dev. Biol. 361, 79-89 (2012).
26. MacArthur, D. G. et al. Guidelines for investigating causality of sequence variants in human disease. Nature 508, 469-476 (2014).
27. Bentley, D. R. et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456, 53-59 (2008).
28. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
29. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
30. Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44, 47-52 (2012).
31. Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101-105 (2011).
32. Lathrop, G. M., Lalouel, J. M., Julier, C. & Ott, J. Strategies for multilocus linkage analysis in humans. Proc. Natl Acad. Sci. USA 81, 3443-3446 (1984).
33. Dubowitz, V. & Sewry, C. A. Muscle Biopsy: a Practical Approach 3rd edn (Saunders/Elsevier, 2007).